Advertisement

Teaching Evidence-based Medicine

  • Franz Porzsolt
  • Heike Leonhardt-Huober
Chapter
  • 998 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bleuler E (1919) Das autistisch-undisziplinäre Denken in der Medizin und seine Überwindung. Springer, HeidelbergGoogle Scholar
  2. 2.
    Coppin C, Porzsolt F, Kumpf J, Coldman A, Wilt T (2004) Immunotherapy for advanced renal cell cancer (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, ChichesterGoogle Scholar
  3. 3.
    Kaplan RM (2003) Zuviel des “Guten”. In: Porzsolt F, Williams AR, Kaplan RM (Eds.) Klinische Ökonomik. Effektivität und Effizienz von Gesundheitsleistungen. Ecomed, Landberg, P 45–49Google Scholar
  4. 4.
    Meissner K (2000) Gibt es organspezifische Placeboeffekte? Placeboeffekte anphysiologischen Parametern und ihre mögliche Vermittlung über kortikale-Organrepräsentationen. Shaker, AachenGoogle Scholar
  5. 5.
    Porzsolt F, Sellenthin C (2000) Der sechste Schritt in der Anwendung der Evidence-based Medicine. Z Aerztl Fortbild Qual Sich 94: 619–620Google Scholar
  6. 6.
    Porzsolt F, Strauss B (2002) EBM — der Konflikt ist lösbar. Deutsches Ärzteblatt 99:761Google Scholar
  7. 7.
    Porzsolt F, Ohletz A, Gardner D, Ruatti H, Meier H, Schlotz-Gorton N, Schrott L. Evidence — based decision making. The six step approach. Evidence-based Medicine. Accepted for publicationGoogle Scholar
  8. 8.
    Porzsolt F, Schlotz-Gorton N, Biller-Andorno N, Thim A, Meissner K, Roeckl-Wiedmann I, Herzberger B, Ziegler R, Gaus W, Pöppel E (2004) Applying Evidence to Support Ethical Decisions: Is the Placebo really Powerless? Science and Engineering Ethics 10:119–132PubMedGoogle Scholar
  9. 9.
    Porzsolt F, Kumpf J, Coppin C, Pöppel E. Stringent application of epidemiologic criteria changes the interpretation of the effects of immunotherapy in advanced renal cell cancer. (unpublished paper)Google Scholar
  10. 10.
    Riethmueller G, Schneider-Gaedicke E, Schlimok G, Schmiegel W, Raab R, Hoeffken K et al. (1994) Randomised Trial of Monoclonal Antibody for Adjuvant Therapy of Resected Dukes’ C Colorectal Carcinoma. Lancet 343:1177–1183Google Scholar
  11. 11.
    Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB (2000) Evidence-based Medicine: How to Practice and Teach. Churchill Livingstone, TorontoGoogle Scholar
  12. 12.
    Tenery RM (1999) Is informed consent always necessary for randomised, controlled trials? New England Journal of Medicine 341:450PubMedGoogle Scholar
  13. 13.
    Zelen M (1979) A new design for Randomised Clinical Trials. New England Journal of Medicine 300:1242–1245PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Franz Porzsolt
  • Heike Leonhardt-Huober

There are no affiliations available

Personalised recommendations